Press Releases

Emmaus Life Sciences Announces Initiation of its Diverticulosis StudyJuly 08, 2019

Study will evaluate change in number and size of colonic diverticula and assess safety.

Emmaus Life Sciences Announces Hiring Of New Endari® Product ManagerJuly 03, 2019

Emmaus Life Sciences, Inc., a leader in sickle cell disease treatment, announced today the hiring of Michael Schwarz as its new Product Manager for Endari®

Emmaus Life Sciences Announces Protocol for Study of Pharmaceutical-grade L-glutamine for the Treatment of DiabetesJune 24, 2019

Emmaus to use its pharmaceutical-grade L-glutamine ("PGLG") in a clinical study to determine its efficacy in lowering blood sugar in patients with type II diabetes.

Emmaus Life Sciences' 'Sideline Sickle Cell' Campaign Teams Up with SCTPN for World Sickle Cell Day Event on June 19June 18, 2019

MYnd Analytics and Emmaus Life Sciences Announce Availability of Definitive Joint Proxy Statement/Prospectus Relating to Merger and Spin-off TransactionJune 12, 2019